Skip to main content

Table 1 Baseline characteristics for all hemato-oncology patients undergoing line insertion

From: Retrospective cohort analysis comparing the incidence of deep vein thromboses between peripherally-inserted and long-term skin tunneled venous catheters in hemato-oncology patients

Patient characteristics

PICC (nā€‰=ā€‰346)

LTSTC (nā€‰=ā€‰237)

Median age (range)

49.7 (15-77)

50.8 (17-72)

Gender:

Ā Ā 

Females (%)

49

49

Males (%)

51

51

Hematological malignancy:

Ā Ā 

AML (%)

36

25

ALL (%)

14

10

HL (%)

5

7

NHL (%)

24

15

MM (%)

15

27

Chronic leukemia (%)

4

9

Misc (%)

2

7

Disease stage:

Ā Ā 

Newly diagnosed (%)

27

10

Relapsed/Refractory (%)

52

53

Remission (%)

21

37

Median duration of dwell time of line in days (range)

64.9 (1-519)

109.4 (1-783)

  1. NB: AMLā€‰=ā€‰Acute Myeloid Leukemia; ALLā€‰=ā€‰Acute Lymphoblastic Leukemia; HLā€‰=ā€‰Hodgkin Lymphoma; NHLā€‰=ā€‰Non-Hodgkin Lymphoma; MMā€‰=ā€‰Multiple Myeloma; Misc. = Miscellaneous consisting of Myelofibrosis, Myelodysplastic Syndrome and Aplastic Anemia; Chronic Leukemia consisting of Chronic Myelomonocytic Leukemia, Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia and T-Prolymphocytic Leukemia; PICCā€‰=ā€‰Peripherally-Inserted Central Venous Catheter; LTSTCā€‰=ā€‰Long-term skin-tunneled venous catheter.